REMINDER: Our user survey closes on Friday, please submit your responses here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJz Capital Regulatory News (JZCP)

Share Price Information for Jz Capital (JZCP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 215.00
Bid: 192.00
Ask: 238.00
Change: 0.00 (0.00%)
Spread: 46.00 (23.958%)
Open: 215.00
High: 216.00
Low: 215.00
Prev. Close: 215.00
JZCP Live PriceLast checked at -
JZ Capital Partners is an Investment Trust

The strategy is to realise investments, pay down debt and reduce commitments to new investments. In addition, the company will return capital to Shareholders while meeting the capital requirements of the portfolio in order to achieve NAV growth.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

JZ Capital Partners Q3 2017 Interim Management Statement

20 Dec 2017 07:00

JZ Capital Partners Ltd - JZ Capital Partners Q3 2017 Interim Management Statement

JZ Capital Partners Ltd - JZ Capital Partners Q3 2017 Interim Management Statement

PR Newswire

London, December 20

JZ CAPITAL PARTNERS LIMITED(a closed-end investment company incorporated with limited liability under the laws of Guernsey with registered number 48761)

 Q3 2017 Interim Management Statement

20 December 2017

LEI: 549300TZCK08Q16HHU44

(Classified Regulated Information, under DTR 6 Annex 1 section 1.1)

JZ Capital Partners Limited (LSE: JZCP.L, the “Company” or “JZCP”), the London listed fund that selectively invests in US and European micro-cap companies and US real estate, today releases its Interim Management Statement for the period 1 September 2017 to 30 November 2017.

Results Highlights

Net Asset Value (“NAV”) of $831.3 million (28/02/17: $848.8 million) NAV per share of $9.91, an increase of 0.3% for the quarter (28/02/17: $10.12) $9.2 million invested during the period, including: $4.2 million invested in K2 Towers II, a new vehicle which is being used to fund a new portfolio of cell tower assets with the same management partners as K2 Towers $4.0 million in follow-on investments in our Williamsburg, Greenpoint, Design District and Wynwood assemblages $37.6 million realised, including: $8.6 million from Nielsen-Kellerman, a designer, manufacturer and distributer of rugged environmental and sports performance instruments $28.7 million from K2 Towers, a build-up of cell tower assets across the United States (a further $2.6 million in proceeds is expected in 2018) Post-period, JZCP received its first distribution of proceeds from the November 2017 sale of Factor Energia, totaling $54.7 million (net of carry) Post-period, JZCP received approximately $11.0 million from the second tranche of sale proceeds of Fidor Bank (net of carry) At the end of the period, the portfolio consisted of 35 micro-cap investments across nine industries and five major real estate “assemblages” (59 total properties) located in New York and South Florida

David Zalaznick, Founder and Investment Advisor of JZCP said: “We are pleased to report the continued steady performance of our portfolio, driven primarily by the realisations from two US micro-cap companies, K2 Towers and Nielsen Kellerman, above their carrying value.

Looking forward, we anticipate further realisations over the next six months which would provide more liquidity to enable us to invest in our growing pipeline of investment opportunities, repay debt or buy back our stock.”

Net Asset Value

NAV per share for the quarter increased from $9.88 to $9.91, or 0.3%.

NAV Returns

Net Asset Value per Ordinary Share as of 1 September 2017........................ ......................................................................................................................$9.88
Change in NAV per share due to capital gains and income received / accrued on investments
US Micro-cap................................................................................................0.24
European Micro-cap....................................................................................... .................................................................................................................... 0.02
Real Estate................................................................................................... (0.05)
Other Investments......................................................................................... .................................................................................................................... (0.01)
Other changes in NAV per share
Change in CULS Fair Value............................................................................ .................................................................................................................... 0.05
Finance Costs............................................................................................... .................................................................................................................... .................................................................................................................... (0.06)
Foreign Exchange Effect................................................................................(0.06)
Expenses and Taxation.................................................................................. (0.10)
Net Asset Value per Ordinary Share as of 30 November 2017....................... ...................................................................................................................... $9.91

The US micro-cap portfolio had a net increase of 24 cents, primarily due to the realisations of K2 Towers and Nielsen Kellerman above carrying value (11 cents and 2 cents, respectively), net accrued income of 9 cents and a write-up at our water vertical (2 cents).

The European micro-cap portfolio had a net increase of 2 cents, primarily due to accrued income.

The real estate portfolio had a net decrease of 5 cents, primarily due to pre-development operating expenses and debt service.

Finally, our other investments had a net decrease of 1 cent, primarily due to the write-off of unused holding companies.

The chart below summarises the cumulative total NAV returns and total shareholder returns for the most recent three-month, nine-month, twelve-month, three-year and five-year period.

30/11/1731/08/1728/02/1730/11/1630/11/1430/11/12
Share price (in GBP)£5.09£5.16£5.38£5.07£4.12£4.34
NAV per share (in USD)$9.91$9.88$10.12$10.13$10.20$9.41
NAV to market price discount30%33%34%37%35%26%
3 month return9 month return12 month return 3 year return5 year return
Dividends paid (in USD)$0.64$1.25
Total Shareholders' return (GBP)1(1.4)%(5.5)%0.3%35.1%40.9%
Total NAV return per share (USD)10.3%(2.1)%(2.2)%3.5%19.3%

______________

Total returns are cumulative and assume that dividends were reinvested

RECENT ACTIVITIES

Significant Investments and Realisations

US Micro-cap Investments – Co-investments

In October 2017, JZCP rolled approximately $4.2 million of proceeds from the K2 Towers realisation into K2 Towers II, a new vehicle which is being used to fund a new portfolio of cell tower assets with the same management partners.

Real Estate Investments

In the three-month period ended 30 November 2017, JZCP invested a total of $4.0 million in follow-on investments in our Williamsburg, Greenpoint, Design District and Wynwood assemblages.

Realisations

Nielsen-Kellerman (“NK”)

JZCP received proceeds of $8.6 million from the sale of NK, a designer, manufacturer and distributer of rugged, waterproof environmental and sports performance instruments for active lifestyles and technical applications. NK’s sale represents a 3.3x realised gross multiple on invested capital and a 19.2% realised gross IRR. JZCP first invested in NK in March 2010.

K2 Towers (“K2”)

JZCP expects to receive total proceeds of $31.3 million from the sale of K2 to one of the largest publicly traded cell tower companies, representing an overall gross multiple of invested capital of 1.5x and a gross internal rate of return of 17.6% in just over two years.

Approximately $4.2 million of these proceeds were re-invested into a new vehicle which is being used to fund a new portfolio of cell tower assets with the same management partners. This transaction provides liquidity to JZCP at an attractive valuation while continuing to build a great cell tower portfolio with further upside.

Factor Energia (“Factor”)

Finally, JZCP realised, at approximately net asset value, its majority equity interest in Factor held through EuroMicrocap Fund-C, L.P. Post-sale, Factor will be majority owned by an affiliate of a major North American public pension fund. As part of this transaction, JZI Fund III, L.P., in which JZCP is an approximately 18.8% limited partner, has agreed to invest €20 million alongside the majority owner and Factor management, representing approximately 25% of the business’ fully diluted equity ownership.

JZCP invested a total of approximately €7.6 million ($9.6 million) in Factor and is expected to receive total gross proceeds (before carry) of approximately €69.7 million ($82.3 million) from the sale (including deferred payments and interim distributions received over the course of the investment), representing an approximate gross multiple of invested capital of 9.2x and an approximate gross IRR of 42.3% in euro-denominated terms.

Post-period, JZCP received its first distribution of proceeds from the November 2017 sale of Factor Energia, totaling $54.7 million (net of carry)

PORTFOLIO SUMMARY

At 30 November 2017, the Company’s portfolio consisted of 35 micro-cap investments across nine major industries and five major real estate “assemblages” (59 total properties) located in New York and South Florida.

($’000) At 30/11/17 At 28/02/17 % Gross Assets 30/11/17
US Micro-cap Portfolio......................426,718424,50237.3%
European Micro-cap Portfolio.............167,868154,27714.7%
Real Estate Portfolio.........................476,772468,59941.7%
Other Portfolio.................................. 16,402 21,802 1.4%
Total Private Investments................ 1,087,760 1,069,180 95.1%
Cash............................................... 55,187 29,064 4.8%
Total Investments (and Cash)........... 1,142,947 1,098,244 99.9%
Other Current Assets........................ 521 511 0.1%
Total Investments (and Cash).............. 1,143,468 1,098,755 100.0%

At 30 November 2017, 4.8% of gross assets were invested in liquid assets (cash). The remaining portion of the portfolio was invested in private investments in US or European micro-cap companies or real estate. These investments are valued at fair value by JZCP’s directors each quarter.

We value our privately held businesses carefully. Our average multiple used for our US micro-cap businesses is 8.2x trailing EBITDA. In addition, we do not have substantial debt in these businesses. The multiple of debt senior to JZCP’s position is approximately 3.6x EBITDA.

Top Ten Investments

Our ten largest investments as of 30 November 2017 are summarised below:

($000’s)Asset CategoryValuation 30/11/17% Gross Assets 30/11/17
Design District Assemblage...........................Real Estate98,8998.6%
Industrial Services Solutions Vertical..............US79,9387.0%
Greenpoint...................................................Real Estate76,3566.7%
Williamsburg Retail Assemblage....................Real Estate72,2536.3%
Healthcare Rev. Cycle Management Vertical...US72,1886.3%
Fulton Assemblage.......................................Real Estate67,4755.9%
EuroMicrocap Fund-C, L.P............................European63,1705.5%
TierPoint......................................................US46,8134.1%
RedBridge....................................................Real Estate36,7743.2%
Jordan Health Products.................................US32,7122.9%
Top Ten Investments....................................646,57856.5%
Remaining Assets........................................496,89043.5%
Gross Assets....................................................1,143,468100.0%

Balance Sheet

Below is a summary of JZCP’s balance sheet as of the relevant dates:

($000’s)30/11/1728/02/17
Cash and cash equivalents...........................55,18729,064
Investments & other assets...........................1,088,2811,069,691
(-) Other net liabilities...................................(251,260)(195,976)
(-) ZDPs due 2022........................................ (60,949) (53,935)
Net Asset Value........................................... 831,259 848,844

At 30 November 2017, “other net liabilities” includes $58.9 million from the issuance of Convertible Unsecured Loan Stock (“CULS”) in July 2014, which carries an interest rate of 6%, and $149.4 million from a six-year term loan with Guggenheim Partners, which carries an interest rate of LIBOR plus 5.75%.

For Further Information:

Ed Berry / Kit Dunford +44 (0) 20 3727 1046 / 1143

FTI Consulting

David Zalaznick +1 212 485 9410

Jordan/Zalaznick Advisers, Inc.

Paul Ford +44 (0) 1481 745001

JZ Capital Partners, Ltd.

About JZCP

JZ Capital Partners (“JZCP”) is one of the oldest closed-end investment companies listed on the London Stock Exchange. It seeks to provide shareholders with a return by investing selectively in US and European microcap companies and US real estate. JZCP receives investment advice from Jordan/Zalaznick Advisers, Inc. (“JZAI”) which is led by David Zalaznick and Jay Jordan. They have worked together for more than 35 years and are supported by teams of investment professionals in New York, Chicago, London and Madrid. JZAI’s experts work with the existing management of micro-cap companies to help build better businesses, create value and deliver strong returns for investors. For more information please visit www.jzcp.com.

Date   Source Headline
17th May 20127:00 amRNSNet Asset Value(s)
27th Apr 20129:07 amRNSNet Asset Value(s)
17th Apr 20124:04 pmRNSNotice of Results - Replacement
13th Apr 20128:57 amRNSNotice of Results
24th Feb 201210:05 amRNSNew Accounting Ref Date
23rd Feb 20129:23 amRNSNet Asset Value(s)
25th Jan 20125:02 pmRNSHolding(s) in Company
25th Jan 20122:17 pmRNSTotal Voting Rights
20th Jan 20124:49 pmRNSHolding(s) in Company
19th Jan 20125:31 pmRNSDirector/PDMR Shareholding
19th Jan 20125:30 pmRNSDirector/PDMR Shareholding
19th Jan 20125:29 pmRNSDirector/PDMR Shareholding
19th Jan 20125:27 pmRNSDirector/PDMR Shareholding
17th Jan 20129:22 amRNSNet Asset Value(s)
16th Jan 201211:46 amRNSHolding(s) in Company
10th Jan 20123:33 pmRNSHolding(s) in Company
29th Dec 201110:03 amRNSHolding(s) in Company
28th Dec 20119:34 amRNSNet Asset Value(s)
22nd Dec 20115:23 pmRNSDirector/PDMR Shareholding
22nd Dec 20119:43 amRNSHolding(s) in Company
20th Dec 20117:00 amRNSJZCP Q3 Interim Management Statement
14th Dec 201111:23 amRNSHolding(s) in Company
6th Dec 20111:58 pmRNSHolding(s) in Company
2nd Dec 20117:00 amRNSCompletes Sale of Wound Care Holdings LLC
1st Dec 20119:17 amRNSConversion of Securities
23rd Nov 20114:17 pmRNSNet Asset Value(s)
31st Oct 20119:52 amRNSNet Asset Value(s)
25th Oct 20112:55 pmRNSDisposal
20th Oct 20114:28 pmRNSHolding(s) in Company
19th Oct 20112:02 pmRNSDividend Declaration
18th Oct 20113:58 pmRNSNet Asset Value(s)
18th Oct 20117:00 amRNSInterim Results 2011
10th Oct 201110:48 amRNSHolding(s) in Company
5th Oct 20119:25 amRNSHolding(s) in Company
27th Sep 20119:28 amRNSHolding(s) in Company
16th Sep 20118:58 amRNSNotice of Interim Results
25th Aug 20117:00 amRNSConversion of Shares
12th Aug 20118:18 amRNSNet Asset Value(s)
18th Jul 20117:00 amRNSAcquisition and realisation of Investments
13th Jul 20118:30 amRNSNet Asset Value(s)
28th Jun 20115:01 pmRNSResult of AGM
21st Jun 201112:44 pmRNSNet Asset Value(s)
21st Jun 20117:00 amRNSInterim Management Statement
26th May 20118:10 amRNSNet Asset Value(s)
24th May 20116:01 pmRNSNotice of AGM
12th May 20118:53 amRNSNet Asset Value(s)
9th May 20113:36 pmRNSDividend Declaration
9th May 20117:00 amRNSAnnual Results for Period Ending 28 February 2011
3rd May 20112:26 pmRNSNotice of Results
13th Apr 20118:33 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.